URAC accredits utilization-management functions—not prior-authorization software

The accreditation object is an organization and its functions

The direct answer on URAC's program page is organizational. Health Utilization Management Accreditation indicates that an organization performs utilization-management functions under the applicable program. URAC describes standards around matters such as confidentiality, conflicts of interest, transparency, effectiveness, and efficiency. The source does not present a prior-authorization application, algorithm, or intake feature as the accredited object.

A buyer therefore needs the accredited legal organization, program, functional module or comprehensive scope, accreditation status, effective period, locations or delegated operations where relevant, and official evidence. A provider's product may support work performed by an accredited organization, but the product relationship and the organization's accreditation record must remain separate.

Five modules keep intake and clinical judgment distinct

URAC lists Pre-Review Screening, Initial Clinical Review, Clinical Decision, Clinical Review, and Comprehensive modules. Its page says pre-review screening begins prior authorization through paper-based, automated, or semi-automated intake. It separately describes initial clinical review, peer review, medical-necessity determinations, development of clinical criteria, and appeals within other modules.

That separation is operationally important. Capturing a request, checking completeness, applying criteria, forwarding a case, making a medical-necessity determination, and resolving an appeal are different states with different actors and evidence. A demonstration should show which function the organization performs, which module is claimed, where licensed or qualified clinical judgment enters, and what is merely transported or automated by software.

Delegation needs exact scope and evidence

URAC notes that its modular approach can matter when an accredited organization acts as a service provider or delegated entity. That does not turn every connected workflow into the same accreditation scope. The delegating organization still needs to understand the function delegated, the entity performing it, applicable contracts and oversight, the accreditation evidence relied on, exclusions, and any work retained by the health plan or another party.

Buyers should test one representative authorization from intake through review, determination, communication, and appeal, then map each step to the accountable organization and evidence. The system should preserve when a case leaves automation, when the record is incomplete, which criteria and version were used, who made the determination, and how exceptions and delegated handoffs are monitored.

Accreditation does not settle every authorization obligation

URAC's page describes a voluntary accreditation program and eligibility conditions; it does not establish that a specific organization is accredited, that every service line is in scope, or that a particular authorization complies with payer, contract, state, federal, clinical, timeliness, notice, privacy, or appeal requirements. Those questions require the official accreditation record and the rules and facts applicable to the case.

This distinction also prevents a common procurement error: scoring a software badge as if it were evidence about clinical decision authority or operating performance. Teams should evaluate the technology's role, the accredited organization's role, workflow configuration, data quality, staffing, qualified review, oversight, and retained case evidence separately. Accreditation can be material evidence without becoming a universal product verdict.

Enterprise buyer test

Translate this change into the exact population, record type, workflow stage, decision owner, effective date, and evidence that could be affected. Ask current or prospective providers to demonstrate the named workflow with representative data and an exception—not a polished feature tour. Record what official documentation establishes, what a provider states, what the team observes, and what remains unresolved.

A defensible review also identifies the dependency outside the product. Authority interpretation, policy configuration, data quality, integrations, human judgment, approval rights, release governance, training, and retained evidence may remain customer or service responsibilities. The evaluation should preserve those boundaries instead of treating a technology claim as the complete operating model.

What we will watch next

Prior Auth Monitor will watch the named source and affected market records for later evidence that changes status, scope, availability, implementation timing, workflow consequence, or the limits of the initial report. A later announcement does not silently overwrite this dated account; the change ledger preserves the sequence.